Personalized medicine: A transformative approach is needed

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 9, 2009, Pages 911-913

  Hudson, Thomas J ^a,b,c  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c 101 College St   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

AUTISM; BREAST CANCER; COLON CANCER; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ENTERITIS; GENE MUTATION; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ARTICLE; BIOLOGICAL MODEL; CANADA; COOPERATION; HEALTH SERVICE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE;

BIOMEDICAL RESEARCH; CANADA; COOPERATIVE BEHAVIOR; GENOME, HUMAN; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MODELS, BIOLOGICAL; PATIENT CARE;

EID: 85047682208     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1090199     Document Type: Note

References (16)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921. (Pubitemid 32165345)
2. Pennisi E. Breakthrough of the year. Human genetic variation. Science 2007;318:1842-3.
3. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008;118:1590-605.
4. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92. (Pubitemid 32222155)
5. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
6. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006;444:444-54.
7. Szatmari P, Paterson AD, Zwaigenbaum L, et al.; Autism Genome Project Consortium. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007;39:319-28.
8. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-5. (Pubitemid 46309843)
9. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91. (Pubitemid 46906617)
10. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604. (Pubitemid 46676115)
11. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009;41:216-20.
12. Villani AC, Lemire M, Fortin G, et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 2009;41:71-6.
13. Mira MT, Alcaïs A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004;427:636-40. (Pubitemid 38248483)
14. Zanke BW, Greenwood CM, Rangrej J, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007;39:989-94. (Pubitemid 47185183)
15. Zhu CQ, da Cunha Santos G, Ding K, et al. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2008;26:4268-75.
16. Molecular Oncology Task Force. Ensuring access to high quality molecular oncology laboratory testing and clinical cancer genetic services in Ontario. Toronto (ON): Cancer Care Ontario; 2008. Available: www.cancercare.on.ca/ documents/MolecOncReport.pdf (accessed 2009 Feb. 12).